Highline Wealth Partners’s Amgen AMGN Stock Holding History

Highline Wealth Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Buy	429 +240	+127%	+$82.2K	0.03%	129
2026 Q1	$66.7K	Buy	189 +22	+13%	+$7.84K	0.02%	147
2025 Q4	$54.8K	Sell	167 -4,004	-96%	-$1.27M	0.02%	131
2025 Q3	$1.18M	Buy	4,171 +69	+2%	+$20K	0.32%	50
2025 Q2	$1.15M	Buy	4,102 +25	+0.6%	+$7.08K	0.34%	51
2025 Q1	$1.27M	Buy	4,077 +34	+0.8%	+$10K	0.43%	48
2024 Q4	$1.05M	Sell	4,043 -2	-0%	-$593	0.34%	51
2024 Q3	$1.3M	Buy	4,045 +2	+0%	+$654	0.44%	50
2024 Q2	$1.26M	Buy	4,043 +1	+0%	+$294	0.48%	47
2024 Q1	$1.15M	Hold	4,042	–	–	0.47%	50
2023 Q4	$1.16M	Buy	4,042 +30	+0.7%	+$8.17K	0.56%	43
2023 Q3	$1.08M	Hold	4,012	–	–	0.67%	36
2023 Q2	$891K	Buy	4,012 +7	+0.2%	+$1.62K	0.56%	48
2023 Q1	$968K	Hold	4,005	–	–	0.66%	43
2022 Q4	$1.05M	Hold	4,005	–	–	0.78%	38
2022 Q3	$903K	Buy	+4,005	New	+$971K	0.73%	35

Other funds holding AMGN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Highline Wealth Partners's AMGN Position: Q2 2026 in Review

Highline Wealth Partners increased its Amgen (AMGN) stake by 127% in Q2 2026, buying an estimated $82.2K and bringing the position to 429 shares worth $155K. The position accounts for 0.03% of the portfolio, ranked #129.

Highline Wealth Partners first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.3M in Q3 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Highline Wealth Partners held 429 shares of Amgen worth $155K as of Q2 2026.
Highline Wealth Partners bought 240 Amgen shares in Q2 2026, an estimated $82.2K.
Amgen made up 0.03% of Highline Wealth Partners's portfolio in Q2 2026, its #129 holding.
Highline Wealth Partners first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
Highline Wealth Partners's Amgen position peaked at $1.3M in Q3 2024.
659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.